Buy Curosurf 80mg Poractant Alfa

Curosurf 80mg (Poractant Alfa) is a surfactant medication used to treat respiratory distress in newborns. This vial contains 80 mg/ml of poractant alfa in a 1.5 ml dose. Store between 2-8°C and use as directed by a healthcare professional.

Strength

(80 mg/ml)1.5 ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Chiesi Farmaceutici S.p.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Curosurf 80mg is primarily used to treat respiratory distress syndrome (RDS) in premature infants. It helps improve lung function by reducing surface tension in the alveoli, making breathing easier. This medication is administered directly into the lungs under medical supervision.

Side Effects

Curosurf 80mg works by restoring surfactant levels in the lungs, which can become deficient in premature babies. This helps stabilize the alveoli and improve oxygen exchange. The effects are typically observed shortly after administration as improved breathing and oxygenation.

Precautions & Warnings

Curosurf 80mg should only be handled and administered by trained healthcare professionals. Store the vials refrigerated between 2-8°C and protect from light. Do not use if the vial is damaged or the solution is discolored. Always follow aseptic techniques during administration.

Avoid Interactions

No specific drug interactions have been established for Curosurf 80mg. However, it is administered in a controlled clinical setting where other medications may be used concurrently. Always inform healthcare providers about all medications being used.

References

Frequently Asked Questions

Curosurf 80mg is used to treat respiratory distress syndrome in premature infants by restoring surfactant levels in the lungs.

It is administered directly into the lungs via endotracheal tube by a healthcare professional.

No, it must be administered in a clinical setting by trained medical staff.

Store between 2-8°C and protect from light. Do not freeze.

It is specifically for premature infants with respiratory distress syndrome under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.